Pacira BioSciences (PCRX) Cash from Operations (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Cash from Operations of 25680000.0 for Q1 2026, down 27.58% year-over-year from 35459000.0 in Q1 2025, and down 41.22% quarter-over-quarter from 43689000.0 in Q4 2025.
Pacira BioSciences (PCRX) Cash from Operations (2010 - 2026) Analysis & Trends
Pacira BioSciences' Cash from Operations history runs 17 years deep, the most recent figure standing at 25680000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 27.58% year-over-year to 25680000.0; the TTM figure through Mar 2026 stood at 142215000.0 (down 19.08% YoY), while the FY2025 annual figure was 151994000.0, down 19.75% from the prior year.
- Cash from Operations for Q1 2026 stood at 25680000.0, down from 43689000.0 in the prior quarter.
- The five-year high for Cash from Operations was 60834000.0 in Q3 2025, with the low at 12012000.0 in Q2 2025.
- The 5-year median for Cash from Operations is 42654000.0 (2022), against an average of 39234470.59.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations soared 156.7% in 2024, then sank 77.44% in 2025.
- Pacira BioSciences' Cash from Operations stood at 42037000.0 in 2022, then grew by 13.2% to 47584000.0 in 2023, then slumped by 30.37% to 33132000.0 in 2024, then jumped by 31.86% to 43689000.0 in 2025, then plunged by 41.22% to 25680000.0 in 2026.
- Business Quant data shows PCRX's Cash from Operations at 25680000.0 in Q1 2026, 43689000.0 in Q4 2025, and 60834000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Pacira BioSciences | 970.37 Mn | 719.34 Mn | 148.24 Mn | 57.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.46 Mn |
| Jun 30, 2026 | 57.46 Mn |
| Mar 31, 2026 | 25.68 Mn |
| Mar 31, 2026 | 25.68 Mn |
| Dec 31, 2025 | 43.69 Mn |
| Dec 31, 2025 | 43.69 Mn |
| Sep 30, 2025 | 60.83 Mn |
| Sep 30, 2025 | 60.83 Mn |
| Jun 30, 2025 | 12.01 Mn |
| Jun 30, 2025 | 12.01 Mn |
| Mar 31, 2025 | 35.46 Mn |
| Mar 31, 2025 | 35.46 Mn |
| Dec 31, 2024 | 33.13 Mn |
| Dec 31, 2024 | 33.13 Mn |
| Sep 30, 2024 | 53.92 Mn |
| Sep 30, 2024 | 53.92 Mn |
| Jun 30, 2024 | 53.24 Mn |
| Jun 30, 2024 | 53.24 Mn |
| Mar 31, 2024 | 49.10 Mn |
| Mar 31, 2024 | 49.10 Mn |